Open Access
Subscription or Fee Access
REVIEW OF HETEROCYCLIC COMPOUNDS AND APPLICATION FOR SUSTAINABILITY
Abstract
Heterocyclic compounds constitute the most extensive and varied group among organic compounds. Today, there are many heterocyclic compounds that are known, and as a result of extensive synthetic research as well as their usefulness in synthetic processes, this number is steadily growing. Heterocyclic molecules play a pivotal role in numerous scientific fields, such as medicinal chemistry and biochemistry, highlighting the blurred boundaries between various chemical disciplines. Heterocyclic chemistry seamlessly extends into numerous other areas within the field of chemistry. The intricate processes of life are intimately connected with heterocyclic compounds. The significant significance of heterocycles to both the pharmaceutical and agrochemical sectors often stems from their presence in the natural world. Heterocyclic systems are produced by synthetic chemistry. Over 90% of brand-new medications include heterocycles and the interface.
References
Pagano, L.; Offidani, M.; Fianchi, L.; Nosari, A.; Candoni, A.; Picardi, M.; Corvatta, L.; D’Antonio, D.; Girmenia, C.; Martino, P.; Del Favero, A. Mucormycosis in hematologic patients. Haematologica, 2004, 89(2), 207-214.
ink
Bitar, D.; Van Cauteren, D.; Lanternier, F.; Dannaoui, E.; Che, D.; Dromer, F.; Desenclos, J.C.; Lortholary, O. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg. Infect. Dis., 2009, 15(9), 1395-1401.
Saegeman, V.; Maertens, J.; Meersseman, W.; Spriet, I.; Verbeken, E.; Lagrou, K. Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg. Infect. Dis., 2010, 16(9), 1456-1458.
Kontoyiannis, D.P.; Yang, H.; Song, J.; Kelkar, S.S.; Yang, X.; Azie, N.; Harrington, R.; Fan, A.; Lee, E.; Spalding, J.R. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: A retrospective study. BMC Infect. Dis., 2016, 16(1), 730.
Lin, E.; Moua, T.; Limper, A.H. Pulmonary mucormycosis: Clinical features and outcomes. Infection, 2017, 45(4), 443-448.
Chakrabarti, A.; Dhaliwal, M. Epidemiology of mucormycosis in India. Curr. Fungal Infect. Rep., 2013, 7(4), 287-292.
ink
Tighadouini, S.; Radi, S.; Benabbes, R.; Youssoufi, M.H.; Shityakov, S.; El Massaoudi, M.; Garcia, Y. Synthesis, biochemical characterization, and theoretical studies of novel β-keto-enol pyridine and furan derivatives as potent antifungal agents. ACS Omega, 2020, 5(28), 17743-17752.
Morcoss, M.M.; Abdelhafez, E.S.M.N.; Ibrahem, R.A.; Abdel-Rahman, H.M.; Abdel-Aziz, M.; Abou El-Ella, D.A. Design, synthesis, mechanistic studies and in silico ADME predictions of benzimidazole derivatives as novel antifungal agents. Bioorg. Chem., 2020, 101103956
Latif, A.; Bibi, S.; Ali, S.; Ammara, A.; Ahmad, M.; Khan, A.; Al-Harrasi, A.; Ullah, F.; Ali, M. New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer’s agents. Drug Dev. Res., 2021, 82(2), 207-216.
Husain, A.; Balushi, K.A.; Akhtar, M.J.; Khan, S.A. Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer’s disease. J. Mol. Struct., 2021, 1241, 130618.
]Mariappan, G.; Prabhat, P.; Sutharson, L.; Banerjee, J.; Patangia, U.; Nath, S. Synthesis and antidiabetic evaluation of benzothiazole derivatives. J. Korean Chem. Soc., 2012, 56(2), 251-256.
Nabil, S.; El-Rahman, S.N.A.; Al-Jameel, S.S.; Elsharif, A.M. Conversion of curcumin into heterocyclic compounds as potent anti-diabetic and anti- histamine agents. Biol. Pharm. Bull., 2018, 41(7), 1071-1077.
Panahi, F.; Yousefi, R.; Mehraban, M.H.; Khalafi-Nezhad, A. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors. Carbohydr. Res., 2013, 380, 81-91.
Dalavai, R.; Gomathi, K.; Naresh, K.; Khan, F-R.N. One-Pot Synthesis of quinolinyl amino nitriles and their antidiabetic, anti-inflammatory, antioxidant, and molecular docking studies. Polycycl. Aromat. Compd., 2020, 1-15.
M. Gupta, Int. J. Physical, Chem. Mat. Sci., 2015, 4(1), 21-24.
M.S. Saini, A. Kumar, J. Dwivedi, R. Singh, Int. J. Pharm. Sci. Res., 2013, 4(3), 66-77.
M. Molnar, V. Pavić, B. Šarkanj, M. Čačić, D. Vuković, J. Klenkar, Heterocycl. Commun., 2017, 23(1), 1-8.
C. Chitra, S. Sudarsan, S. Sakthivel, S. Guhanathan, Int. J. Biol. Macromol., 2017, 95, 363-375.
H.I. Wahbi, C.Y. Ishak, A. Khalid, T. Adlan, Int. J. Pharm. Phytopharmacol. Res., 2014, 4(1), 13-19.
D.V. Sa whney, S.N.S. Bhutani, Chem. Inform., 1987, 18(43), 55-62. [7] D. Li, J. Chen, J. Ye, X. Zhai, J. Song, C. Jiang, J. Wang, H. Zhang, X. Jia, F. Zhu, J. Ethnopharmacol., 2017, 196(100), 66-74.
Refbacks
- There are currently no refbacks.